Aire controls mesenchymal stem cell-mediated suppression in chronic colitis

Molecular Therapy

Volumn 20, Issue 1, 2012, Pages 178-186

  Parekkadan, Biju ^a   Fletcher, Anne L ^b,c   Li, Matthew ^a   Tjota, Melissa Y ^b,c   Bellemare Pelletier, Angelique ^b,c   Milwid, Jack M ^a   Lee, Je Wook ^b,c   Yarmush, Martin L ^a   Turley, Shannon J ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; CYTOKINE; EARLY T CELL ACTIVATION FACTOR 1; MESSENGER RNA; MITOCHONDRIAL ENZYME; UNCLASSIFIED DRUG;

AIRE GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MONITORING; CHRONIC DISEASE; COLON CROHN DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; FEMALE; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR DYNAMICS; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 84856958929     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.192     Document Type: Article

References (50)

1. Pittenger, MF, Mackay, AM, Beck, SC, Jaiswal, RK, Douglas, R, Mosca, JD et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
2. Dennis, JE and Caplan, AI (1996). Analysis of the developmental potential of conditionally immortal marrow-derived mesenchymal progenitor cells isolated from the H-2Kb-tsA58 transgenic mouse. Connect Tissue Res 35: 93-99. (Pubitemid 27118841)
3. Le Blanc, K, Rasmusson, I, Sundberg, B, Götherström, C, Hassan, M, Uzunel, M et al. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441. (Pubitemid 38586721)
4. Németh, K, Leelahavanichkul, A, Yuen, PS, Mayer, B, Parmelee, A, Doi, K et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49.
5. Ortiz, LA, Gambelli, F, McBride, C, Gaupp, D, Baddoo, M, Kaminski, N et al. (2003). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100: 8407-8411. (Pubitemid 36842558)
6. Gnecchi, M, He, H, Liang, OD, Melo, LG, Morello, F, Mu, H et al. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11: 367-368. (Pubitemid 40562318)
7. Bartholomew, A, Sturgeon, C, Siatskas, M, Ferrer, K, McIntosh, K, Patil, S et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-48. (Pubitemid 34059216)
8. Zappia, E, Casazza, S, Pedemonte, E, Benvenuto, F, Bonanni, I, Gerdoni, E et al. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761. (Pubitemid 41208591)
9. Lee, RH, Seo, MJ, Reger, RL, Spees, JL, Pulin, AA, Olson, SD et al. (2006). Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 103: 17438-17443. (Pubitemid 44788987)
10. Parekkadan, B, Tilles, AW and Yarmush, ML (2008). Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells 26: 1913-1919.
11. Augello, A, Tasso, R, Negrini, SM, Cancedda, R and Pennesi, G (2007). Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56: 1175-1186. (Pubitemid 46608642)
12. Gu, Z, Akiyama, K, Ma, X, Zhang, H, Feng, X, Yao, G et al. (2010). Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 19: 1502-1514.
13. Parekkadan, B and Milwid, JM (2010). Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12: 87-117.
14. Zhang, W, Ge, W, Li, C, You, S, Liao, L, Han, Q et al. (2004). Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 13: 263-271. (Pubitemid 38738368)
15. Aggarwal, S and Pittenger, MF (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822. (Pubitemid 40223708)
16. Beyth, S, Borovsky, Z, Mevorach, D, Liebergall, M, Gazit, Z, Aslan, H et al. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 2214-2219. (Pubitemid 40731815)
17. Sotiropoulou, PA, Perez, SA, Gritzapis, AD, Baxevanis, CN and Papamichail, M (2006). Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24: 74-85.
18. González, MA, Gonzalez-Rey, E, Rico, L, Büscher, D and Delgado, M (2009). Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136: 978-989.
19. Krampera, M, Glennie, S, Dyson, J, Scott, D, Laylor, R, Simpson, E et al. (2003). Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood 101: 3722-3729. (Pubitemid 36857965)
20. Rasmusson, I, Ringdén, O, Sundberg, B and Le Blanc, K (2003). Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76: 1208-1213. (Pubitemid 37339646)
21. Parekkadan, B, Upadhyay, R, Dunham, J, Iwamoto, Y, Mizoguchi, E, Mizoguchi, A et al. (2011). Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes. Gastroenterology 140: 966-975.
22. Zhang, J, Li, Y, Lu, M, Cui, Y, Chen, J, Noffsinger, L et al. (2006). Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J Neurosci Res 84: 587-595. (Pubitemid 44196699)
23. Kassis, I, Grigoriadis, N, Gowda-Kurkalli, B, Mizrachi-Kol, R, Ben-Hur, T, Slavin, S et al. (2008). Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 65: 753-761. (Pubitemid 351831453)
24. Kawada, H, Fujita, J, Kinjo, K, Matsuzaki, Y, Tsuma, M, Miyatake, H et al. (2004). Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 104: 3581-3587. (Pubitemid 39564430)
25. Lee, RH, Pulin, AA, Seo, MJ, Kota, DJ, Ylostalo, J, Larson, BL et al. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5: 54-63.
26. Zangi, L, Margalit, R, Reich-Zeliger, S, Bachar-Lustig, E, Beilhack, A, Negrin, R et al. (2009). Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells 27: 2865-2874.
27. Ren, G, Zhang, L, Zhao, X, Xu, G, Zhang, Y, Roberts, AI et al. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-150. (Pubitemid 351181031)
28. Meisel, R, Zibert, A, Laryea, M, Göbel, U, Däubener, W and Dilloo, D (2004). Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103: 4619-4621. (Pubitemid 38745993)
29. Yagi, H, Soto-Gutierrez, A, Navarro-Alvarez, N, Nahmias, Y, Goldwasser, Y, Kitagawa, Y et al. (2010). Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther 18: 1857-1864.
30. Anderson, MS, Venanzi, ES, Klein, L, Chen, Z, Berzins, SP, Turley, SJ et al. (2002). Projection of an immunological self shadow within the thymus by the aire protein. Science 298: 1395-1401. (Pubitemid 35346134)
31. Gardner, JM, Devoss, JJ, Friedman, RS, Wong, DJ, Tan, YX, Zhou, X et al. (2008). Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321: 843-847.
32. Abramson, J, Giraud, M, Benoist, C and Mathis, D (2010). Aire's partners in the molecular control of immunological tolerance. Cell 140: 123-135.
33. Hangen, E, Blomgren, K, Bénit, P, Kroemer, G and Modjtahedi, N (2010). Life with or without AIF. Trends Biochem Sci 35: 278-287.
34. Jackson, SH, Devadas, S, Kwon, J, Pinto, LA and Williams, MS (2004). T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5: 818-827. (Pubitemid 39172975)
35. Fletcher, AL, Lukacs-Kornek, V, Reynoso, ED, Pinner, SE, Bellemare-Pelletier, A, Curry, MS et al. (2010). Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J Exp Med 207: 689-697.
36. Miyamoto, T, Iwasaki, H, Reizis, B, Ye, M, Graf, T, Weissman, IL et al. (2002). Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev Cell 3: 137-147. (Pubitemid 34778402)
37. Tondreau, T, Lagneaux, L, Dejeneffe, M, Massy, M, Mortier, C, Delforge, A et al. (2004). Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation 72: 319-326. (Pubitemid 41702124)
38. Gardner, JM, Fletcher, AL, Anderson, MS and Turley, SJ (2009). AIRE in the thymus and beyond. Curr Opin Immunol 21: 582-589.
39. Laan, M, Kisand, K, Kont, V, Möll, K, Tserel, L, Scott, HS et al. (2009). Autoimmune regulator deficiency results in decreased expression of CCR4 and CCR7 ligands and in delayed migration of CD4+ thymocytes. J Immunol 183: 7682-7691.
40. Lindh, E, Lind, SM, Lindmark, E, Hässler, S, Perheentupa, J, Peltonen, L et al. (2008). AIRE regulates T-cell-independent B-cell responses through BAFF. Proc Natl Acad Sci USA 105: 18466-18471.
41. Schaller, CE, Wang, CL, Beck-Engeser, G, Goss, L, Scott, HS, Anderson, MS et al. (2008). Expression of Aire and the early wave of apoptosis in spermatogenesis. J Immunol 180: 1338-1343.
42. Nishikawa, Y, Hirota, F, Yano, M, Kitajima, H, Miyazaki, J, Kawamoto, H et al. (2010). Biphasic Aire expression in early embryos and in medullary thymic epithelial cells before end-stage terminal differentiation. J Exp Med 207: 963-971.
43. Cantor, H and Shinohara, ML (2009). Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nat Rev Immunol 9: 137-141.
44. McAllister, SS, Gifford, AM, Greiner, AL, Kelleher, SP, Saelzler, MP, Ince, TA et al. (2008). Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133: 994-1005. (Pubitemid 351787747)
45. Shinohara, ML, Lu, L, Bu, J, Werneck, MB, Kobayashi, KS, Glimcher, LH et al. (2006). Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol 7: 498-506.
46. Sudres, M, Norol, F, Trenado, A, Grégoire, S, Charlotte, F, Levacher, B et al. (2006). Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 176: 7761-7767. (Pubitemid 43849077)
47. Schurgers, E, Kelchtermans, H, Mitera, T, Geboes, L and Matthys, P (2010). Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis Res Ther 12: R31.
48. Newman, RE, Yoo, D, LeRoux, MA and Danilkovitch-Miagkova, A (2009). Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm Allergy Drug Targets 8: 110-123.
49. Baddoo, M, Hill, K, Wilkinson, R, Gaupp, D, Hughes, C, Kopen, GC et al. (2003). Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89: 1235-1249. (Pubitemid 36959389)
50. Peister, A, Mellad, JA, Larson, BL, Hall, BM, Gibson, LF and Prockop, DJ (2004). Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103: 1662-1668. (Pubitemid 38268957)